Traphagen Investment Advisors’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30,500	Closed	-$19.4K	–	190
2025 Q1	$19.4K	Hold	30,500	–	–	﹤0.01%	181
2024 Q4	$31.4K	Buy	+30,500	New	+$31.4K	﹤0.01%	176